Table 1 Clinical characteristics of MS patients
From: Clinical predictors to cognitive impairment in multiple sclerosis patients
| Â | Patients | |
|---|---|---|
| Â | Frequency (N = 45) | Percentage |
Type of MS | ||
 RRMS | 30 | 66.7 |
 SPMS | 15 | 33.3 |
Type of first attack | ||
 Motor | 22 | 48.9 |
 Cerebellar | 13 | 28.9 |
 Visual | 7 | 15.6 |
 Sensory | 3 | 6.7 |
Attack/year | ||
 One | 9 | 20.0 |
 Two | 23 | 51.1 |
 Three | 13 | 28.9 |
Treatment | ||
 Interferon B1b | 13 | 28.9 |
  Monthly cyclophosphamide + methylprednisolone | 11 | 24.4 |
  Fingolimod | 8 | 17.8 |
 Interferon Beta 1a | 7 | 15.6 |
  Azathioprine | 5 | 11.1 |
  Cyclophosphamide | 1 | 2.2 |